Miscellaneous News

emblem21

Major
Registered Member
Please, Log in or Register to view URLs content!
Right, they like to remind others of their privileges, but for how long can they do this


What is this I don’t even. At the very least, at least Steve Job won’t witness the collapse of the company he started once China develops a complete alternative to apple and decides that apple is no longer necessary. I mean, the last couple of releases from apple don’t seem to be all that great
 

emblem21

Major
Registered Member
In other words, "China, my dogs are watching you in Asia-Pacific while I am busy setting fires on Europe."
This I got to see, do these dogs have the balls to start a fight because a war ship from one of these dogs is still stuck in Tonga waiting for repairs while the other one is having second thoughts. At this point, all China needs right now is a nice cold bai jou and 0g bed and it’s all sweet from here
 

Appix

Senior Member
Registered Member

China biotech has moving U.S. target on the back​


Pharmaceutical company WuXi Biologics
Please, Log in or Register to view URLs content!
plunged 23% on Tuesday after Washington added it and 32 other Chinese groups to a list that would make U.S. imports of components like bioreactors much more painful. The $34 billion contract drugmaker rushed to explain
Please, Log in or Register to view URLs content!
that the list is not the much-feared entity black list, and hinted things will improve once China’s Covid-19 restrictions ease and field inspections can be completed. But it’s the second time in merely two months that the company was hammered
Please, Log in or Register to view URLs content!
out of fears over its heavy U.S. exposure as bilateral ties sour.

Even if WuXi Biologics’ planned mainland factories eventually make it self-sufficient for parts, the company is a moving target with over half of its revenue from North American clients, including a large proportion from the United States. The “Unverified List” may just be a starter proving the multiple ways that Washington can move to curb Chinese champions. Wuxi’s rich valuation, at 47 times next 12 months earnings per Refinitiv, is another reason to sell. (By Yawen Chen)

Source:
Please, Log in or Register to view URLs content!
 
Top